BID Equity Fund II acquires analytics platform Carenity forging a new life science group with XClinical
BID Equity Fund II, a fund advised by BID Equity, acquires France-based Carenity, an anlytics platform supporting +500,000 patients and caregivers worldwide.
The acquisition enables BID Equity’s life science platform around software vendor XClinical to gain access to real-world patient data (RWD), digital solutions for patient recruitment, and feasibility studies.
With its innovative platform, Carenity delivers timely and compliant direct-to-patient research solutions to the life sciences industry that fuel the development of better medicines and services. Carenity’s social platform is available in France, UK, Italy, Germany, Spain and the US.